Androgen Receptor Pathway Inhibitor: Clinical Trials

1 trial of Androgen Receptor Pathway Inhibitor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Androgen Receptor Pathway Inhibitor: new trials by email Literature Review of Androgen Receptor Pathway Inhibitor trials Research Report on Androgen Receptor Pathway Inhibitor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
Androgen Receptor Pathway Inhibitor, Transdermal Estrogen, Bone Scan - Castration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma
Phase 2RecruitingFred Hutchinson Cancer Center602026-11-012026-10-16

Conditions studied

Prostatic Neoplasms (1)

Sponsors

Fred Hutchinson Cancer Center (1)

Countries

United States (1)

Top investigators

Michael Schweizer, MD (1)